Matches in SemOpenAlex for { <https://semopenalex.org/work/W2280494965> ?p ?o ?g. }
Showing items 1 to 72 of
72
with 100 items per page.
- W2280494965 abstract "Abstract Background The bacterial clustered regularly interspaced short palindromic repeats (CRISPR)–cas9 system has recently emerged as a highly efficient gene-editing technique, in which the enzyme cas9 cleaves a genetic target under guidance from a CRISPR guide RNA. Glioma stem-cells are a useful model for the study of glioblastomas, but whether CRISPR–cas9 can be efficiently applied in this model is unknown. We aimed to derive and test a single cas9-expressing clone from a glioma stem-cell line. Methods An established human glioblastoma stem-cell line, NCH421K, was stably cultured in neural stem-cell conditions as neurospheres. A cas9 vector was designed with piggybac repeats for genome integration, and a neomycin-resistance cassette. The cas9 vector and a piggybac transposase vector were transfected into the glioma stem cells and selected with G418. The neurospheres were then dissociated into single cells, and flow sorting was used to transfer one cell to each well of a 96-well plate. Findings With this approach, expression of cas9 RNA in the transfected glioma stem-cell line was over 100 times higher than in wild-type cells, as demonstrated by real-time PCR. Repeat testing showed that the level of cas9 expression did not decrease over 2 months, indicating stable expression. Between 2 and 4 weeks after single-cell dissociation, single clonal neurospheres were isolated. Expansion of three such clones revealed cas9 expression in all of them. Functional testing with green fluorescence protein (GFP) expression (revealed by flow cytometry) demonstrated that transfection with a CRISPR guide RNA against GFP caused complete loss of GFP expression in over 90% of cloned glioma stem cells. Interpretation Our results demonstrate that isolation of a single glioma stem-cell clone engineered to express cas9 can generate highly efficient gene knock-outs. This model will allow unprecedented functional genomic screens of glioma stem cells on a genome-wide scale to identify novel cancer genes. Funding Wellcome Trust Clinical Research Training Fellowship." @default.
- W2280494965 created "2016-06-24" @default.
- W2280494965 creator A5080336450 @default.
- W2280494965 creator A5087532232 @default.
- W2280494965 date "2016-02-01" @default.
- W2280494965 modified "2023-09-27" @default.
- W2280494965 title "Use of CRISPR–cas9 gene targeting for genome-scale CRISPR screening in a glioma stem-cell line" @default.
- W2280494965 doi "https://doi.org/10.1016/s0140-6736(16)00465-7" @default.
- W2280494965 hasPublicationYear "2016" @default.
- W2280494965 type Work @default.
- W2280494965 sameAs 2280494965 @default.
- W2280494965 citedByCount "0" @default.
- W2280494965 crossrefType "journal-article" @default.
- W2280494965 hasAuthorship W2280494965A5080336450 @default.
- W2280494965 hasAuthorship W2280494965A5087532232 @default.
- W2280494965 hasConcept C104317684 @default.
- W2280494965 hasConcept C132455925 @default.
- W2280494965 hasConcept C136834591 @default.
- W2280494965 hasConcept C148738053 @default.
- W2280494965 hasConcept C153911025 @default.
- W2280494965 hasConcept C162746124 @default.
- W2280494965 hasConcept C20875687 @default.
- W2280494965 hasConcept C2778227246 @default.
- W2280494965 hasConcept C2778630268 @default.
- W2280494965 hasConcept C28328180 @default.
- W2280494965 hasConcept C54009773 @default.
- W2280494965 hasConcept C54355233 @default.
- W2280494965 hasConcept C553184892 @default.
- W2280494965 hasConcept C86803240 @default.
- W2280494965 hasConcept C98108389 @default.
- W2280494965 hasConceptScore W2280494965C104317684 @default.
- W2280494965 hasConceptScore W2280494965C132455925 @default.
- W2280494965 hasConceptScore W2280494965C136834591 @default.
- W2280494965 hasConceptScore W2280494965C148738053 @default.
- W2280494965 hasConceptScore W2280494965C153911025 @default.
- W2280494965 hasConceptScore W2280494965C162746124 @default.
- W2280494965 hasConceptScore W2280494965C20875687 @default.
- W2280494965 hasConceptScore W2280494965C2778227246 @default.
- W2280494965 hasConceptScore W2280494965C2778630268 @default.
- W2280494965 hasConceptScore W2280494965C28328180 @default.
- W2280494965 hasConceptScore W2280494965C54009773 @default.
- W2280494965 hasConceptScore W2280494965C54355233 @default.
- W2280494965 hasConceptScore W2280494965C553184892 @default.
- W2280494965 hasConceptScore W2280494965C86803240 @default.
- W2280494965 hasConceptScore W2280494965C98108389 @default.
- W2280494965 hasLocation W22804949651 @default.
- W2280494965 hasOpenAccess W2280494965 @default.
- W2280494965 hasPrimaryLocation W22804949651 @default.
- W2280494965 hasRelatedWork W2099949735 @default.
- W2280494965 hasRelatedWork W2233986953 @default.
- W2280494965 hasRelatedWork W2318717934 @default.
- W2280494965 hasRelatedWork W2423540147 @default.
- W2280494965 hasRelatedWork W2548883368 @default.
- W2280494965 hasRelatedWork W2566691421 @default.
- W2280494965 hasRelatedWork W2744234226 @default.
- W2280494965 hasRelatedWork W2769059387 @default.
- W2280494965 hasRelatedWork W2790984880 @default.
- W2280494965 hasRelatedWork W2792883464 @default.
- W2280494965 hasRelatedWork W2890225178 @default.
- W2280494965 hasRelatedWork W2950101654 @default.
- W2280494965 hasRelatedWork W2977551986 @default.
- W2280494965 hasRelatedWork W3035942527 @default.
- W2280494965 hasRelatedWork W3132138738 @default.
- W2280494965 hasRelatedWork W3133924339 @default.
- W2280494965 hasRelatedWork W904621838 @default.
- W2280494965 hasRelatedWork W2854660630 @default.
- W2280494965 hasRelatedWork W2957498433 @default.
- W2280494965 hasRelatedWork W2965759751 @default.
- W2280494965 isParatext "false" @default.
- W2280494965 isRetracted "false" @default.
- W2280494965 magId "2280494965" @default.
- W2280494965 workType "article" @default.